<html>
<head>PUBMED IDs for SIIR</head>
<body bgcolor='#C5F0F2'><h1>SIIR</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7592688/'>The Ser36-Ser37 pair in HeLa nuclear protein p21/SIIR mediates Ser/Thr phosphorylation and is essential for Rous sarcoma virus long terminal repeat repression.</a> October 27  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/10051408/'>Genomic structure and chromosomal localization of TCEAL1, a human gene encoding the nuclear phosphoprotein p21/SIIR.</a> March 3  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/12649204/'>Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.</a> March 22  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/17988723/'>MÃ¼llerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.</a> November 9  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19208807/'>Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.</a> April 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22782891/'>Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/27774523/'>Interferon-Gamma Receptor Signaling Plays an Important Role in Restraining Murine Ovarian Tumor Progression.</a> October 25  2016<br></body></html>
